Active Ingredients (In Each Extended-Release Bi-Layer Tablet)
Guaifenesin 600 mg
Pseudoephedrine HCl 60 mg
The following Structured Product Label (SPL) was submitted to the FDA by Kroger Company for the product Mucus D (NDC 30142-739). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredients (in each extended-release bi-layer tablet), purposes, uses, warnings, ask a doctor before use if you have, when using this product, stop use and ask a doctor if, if pregnant or breast-feeding,, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Guaifenesin 600 mg
Pseudoephedrine HCl 60 mg
Expectorant
Nasal Decongestant
Do not use if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).
carbomer homopolymer type B, colloidal silicon dioxide, FD&C yellow #6 aluminum lake, hypromellose, magnesium stearate, microcrystalline cellulose, sodium starch glycolate
Call 1-800-632-6900
Kroger® health
COMPARE TO MUCINEX® D ACTIVE INGREDIENTS
Mucus-D
Guaifenesin and Pseudoephedrine Hydrochloride Extended-Release Bi-Layer Tablets, 600 mg/60 mg
Expectorant and Nasal Decongestant
12 HOUR
ACTUAL SIZE
CLEARS NASAL/SINUS CONGESTION, THINS AND LOOSENS MUCUS, IMMEDIATE AND EXTENDED RELEASE
36 EXTENDED-RELEASE BI-LAYER TABLETS
* Please review the disclaimer below.